Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS)

Experimental Dermatology

Volumn 25, Issue 1, 2016, Pages 17-19

  Vahidnezhad, Hassan ^a,b   Youssefian, Leila ^a,c   Uitto, Jouni ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CLOVES syndrome; Fibroadipose hyperplasia; Klippel Trenaunay syndrome; PIK3CA related overgrowth spectrum

Indexed keywords

PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; AKT1 PROTEIN, HUMAN; MTOR PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN; PROTEIN KINASE B; TARGET OF RAPAMYCIN KINASE;

ANGIOOSTEOHYPERTROPHY SYNDROME; ARTICLE; DISEASE CLASSIFICATION; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; MULTIPLE MALFORMATION SYNDROME; PIK3CA RELATED OVERGROWTH SPECTRUM; ADIPOSE TISSUE; CELL PROLIFERATION; CLASSIFICATION; GENETICS; HYPERPLASIA; KLIPPEL-TRENAUNAY-WEBER SYNDROME; LIPOMA; METABOLISM; MISSENSE MUTATION; MUSCULOSKELETAL ABNORMALITIES; MUTATION; NEVUS; PATHOLOGY; PHENOTYPE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; VASCULAR MALFORMATIONS;

ADIPOSE TISSUE; CELL PROLIFERATION; HUMANS; HYPERPLASIA; KLIPPEL-TRENAUNAY-WEBER SYNDROME; LIPOMA; MUSCULOSKELETAL ABNORMALITIES; MUTATION; MUTATION, MISSENSE; NEVUS; PHENOTYPE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; VASCULAR MALFORMATIONS;

EID: 84953911725     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12826     Document Type: Article

References (45)

1. Klippel M, Trenaunay P. Arch Gen Med 1900: 185: 641-672.
2. Parkes Weber F. The Lancet 1907: 170: 160-162.
3. Jacob A G, Driscoll D J, Shaughnessy W J et al. Mayo Clin Proc 1998: 73: 28-36.
4. Cohen M M Jr. Am J Med Genet 2000: 93: 171-175.
5. Stefanov-Kiuri S, Fernandez-Heredero A. N Engl J Med 2014: 371: 2114.
6. Clayton-Smith J, Kerr B, Brunner H et al. Clin Dysmorphol 1997: 6: 291-302.
7. Moore C A, Toriello H V, Abuelo D N et al. Am J Med Genet 1997: 70: 67-73.
8. Toriello H V, Mulliken J B. Am J Med Genet A 2007: 143A: 3009.
9. Mirzaa G M, Conway R L, Gripp K W et al. Am J Med Genet A 2012: 158A: 269-291.
10. Mirzaa G M, Dobyns W B. Am J Med Genet A 2013: 161A: 2115-2116.
11. Sapp J C, Turner J T, van de Kamp J M et al. Am J Med Genet A 2007: 143A: 2944-2958.
12. Gucev Z S, Tasic V, Jancevska A et al. Am J Med Genet A 2008: 146A: 2688-2690.
13. Alomari A I. Am J Med Genet A 2009: 149A: 294.
14. Youssefian L, Vahidnezhad H, Baghdadi T et al. J Invest Dermatol 2015: 135: 1450-1453.
15. Keppler-Noreuil K M, Rios J J, Parker V E et al. Am J Med Genet A 2015: 167A: 287-295.
16. Kurek K C, Luks V L, Ayturk U M et al. Am J Hum Genet 2012: 90: 1108-1115.
17. Lindhurst M J, Parker V E, Payne F et al. Nat Genet 2012: 44: 928-933.
18. Riviere J B, Mirzaa G M, O'Roak B J et al. Nat Genet 2012: 44: 934-940.
19. Biesecker L G, Spinner N B. Nat Rev Genet 2013: 14: 307-320.
20. Hafner C, Lopez-Knowles E, Luis N M et al. Proc Natl Acad Sci U S A 2007: 104: 13450-13454.
21. Groesser L, Herschberger E, Landthaler M et al. Br J Dermatol 2012: 166: 784-788.
22. Yuan T L, Cantley L C. Oncogene 2008: 27: 5497-5510.
23. Lindhurst M J, Sapp J C, Teer J K et al. N Engl J Med 2011: 365: 611-619.
24. Hussain K, Challis B, Rocha N et al. Science 2011: 334: 474.
25. Marsh D J, Trahair T N, Martin J L et al. Nat Clin Pract Oncol 2008: 5: 357-361.
26. Luks V L, Kamitaki N, Vivero M P et al. J Pediatr 2015: 166: 1048-1054.
27. Rauen K A. Annu Rev Genomics Hum Genet 2013: 14: 355-369.
28. Tidyman W E, Rauen K A. Curr Opin Genet Dev 2009: 19: 230-236.
29. Bezniakow N, Gos M, Obersztyn E. Dev Period Med 2014: 18: 285-296.
30. Urbina F, Sazunic I, Murray G. Pediatr Dermatol 2004: 21: 154-159.
31. Caux F, Plauchu H, Chibon F et al. Eur J Hum Genet 2007: 15: 767-773.
32. Nakashima M, Miyajima M, Sugano H et al. J Hum Genet 2014: 59: 691-693.
33. Eerola I, Boon L M, Mulliken J B, et al. Am J Hum Genet 2003: 73: 1240-1249.
34. Ma X M, Blenis J. Nat Rev Mol Cell Biol 2009: 10: 307-318.
35. Shimobayashi M, Hall M N. Nat Rev Mol Cell Biol 2014: 15: 155-162.
36. Loconte D C, Grossi V, Bozzao C et al. PLoS One 2015: 10: e0123092.
37. Keppler-Noreuil K M, Sapp J C, Lindhurst M J et al. Am J Med Genet A 2014: 164A: 1713-1733.
38. Alomari A I, Spencer S A, Arnold R W et al. J Pediatr Orthop 2014: 34: 109-117.
39. Maclellan R A, Luks V L, Vivero M P et al. Plast Reconstr Surg 2014: 133: 12e-19e.
40. Osborn A J, Dickie P, Neilson D E et al. Hum Mol Genet 2015: 24: 926-938.
41. Rios J J, Paria N, Burns D K et al. Hum Mol Genet 2013: 22: 444-451.
42. Castiglioni C, Bertini E, Orellana P et al. Am J Med Genet A 2014: 164A: 2365-2369.
43. Cohen A S, Townsend K N, Xiang Q S et al. Am J Med Genet A 2014: 164A: 2360-2364.
44. Hafner C, Hartmann A, Vogt T. J Invest Dermatol 2007: 127: 1572-1573.
45. Jansen L A, Mirzaa G M, Ishak G E et al. Brain 2015: 138: 1613-1628.